These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12487034)

  • 1. Homocysteine and arterial disease. Experimental mechanisms.
    Cook JW; Taylor LM; Orloff SL; Landry GJ; Moneta GL; Porter JM
    Vascul Pharmacol; 2002 May; 38(5):293-300. PubMed ID: 12487034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
    Van den Berg M; Boers GH; Franken DG; Blom HJ; Van Kamp GJ; Jakobs C; Rauwerda JA; Kluft C; Stehouwert CD
    Eur J Clin Invest; 1995 Mar; 25(3):176-81. PubMed ID: 7781664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial marker proteins in hyperhomocysteinemia.
    de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
    Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteinemia and endothelial damage after methionine load.
    Hladovec J; Sommerová Z; Písaríková A
    Thromb Res; 1997 Nov; 88(4):361-4. PubMed ID: 9526959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
    Weiss N; Keller C; Hoffmann U; Loscalzo J
    Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine in myointimal hyperplasia.
    Hansrani M; Gillespie JI; Stansby G
    Eur J Vasc Endovasc Surg; 2002 Jan; 23(1):3-10. PubMed ID: 11748941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    Domagała TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K; Böger RH
    Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
    Takamitsu Y; Nakanishi T
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S95-9. PubMed ID: 11576931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O; Weger M; Renner W; Konetschny R
    Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
    Rogolino A; Farsi A; Brunelli T; Ilari I; Capanni M; Domeneghetti MP; Dorigo W; Lombardi R; Pulli R; Pratesi C; Gensini GF
    Minerva Cardioangiol; 1999 Dec; 47(12):583. PubMed ID: 10670214
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis.
    Zhao J; Chen H; Liu N; Chen J; Gu Y; Chen J; Yang K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2695-2699. PubMed ID: 28986198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.
    Medina MA
    Circ Res; 2008 Apr; 102(8):869-70. PubMed ID: 18436800
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.
    Woo KS; Chook P; Lolin YI; Cheung AS; Chan LT; Sun YY; Sanderson JE; Metreweli C; Celermajer DS
    Circulation; 1997 Oct; 96(8):2542-4. PubMed ID: 9355891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.